Payment overview · 2025
General Payments
$14,271.04
86 reported records · 19 companies
Healthcare provider profile · identity verified
Michael Ginsburg, MD
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · MIAMI, FL · NPI 1417189549
Verified facts
What the public records show
CMS Open Payments records show Michael Ginsburg, MD received $14,271.04 in general payments during 2025 across 86 reported records.
Medtronic, Inc. accounted for 36.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 36 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$5,209.45 | 36.5% | 9 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $3,755.04 | 26.3% | 19 | 2025 |
| Scientia Vascular | Unresolved — no canonical attribution shown | $2,000.00 | 14.0% | 1 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $714.16 | 5.0% | 13 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $666.35 | 4.7% | 17 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $458.06 | 3.2% | 4 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $406.67 | 2.9% | 1 | 2025 |
| Siemens Medical Solutions USA, Inc. | Unresolved — no canonical attribution shown | $284.37 | 2.0% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $184.66 | 1.3% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $163.54 | 1.1% | 2 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $125.40 | 0.9% | 2 | 2025 |
| Veryan Medical Incorporated | Unresolved — no canonical attribution shown | $47.74 | 0.3% | 2 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $45.58 | 0.3% | 2 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $44.04 | 0.3% | 2 | 2025 |
| Sirtex Medical Inc | Unresolved — no canonical attribution shown | $44.03 | 0.3% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $37.82 | 0.3% | 2 | 2025 |
| MicroVention, Inc. | Unresolved — no canonical attribution shown | $30.78 | 0.2% | 1 | 2025 |
| Ethicon US, LLC | Unresolved — no canonical attribution shown | $27.10 | 0.2% | 1 | 2025 |
| TriSalus Life Sciences, Inc. | Unresolved — no canonical attribution shown | $26.25 | 0.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,675.00 | 1 |
| Consulting Fee | $4,406.67 | 4 |
| Food and Beverage | $3,815.60 | 72 |
| Travel and Lodging | $1,373.77 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CONCERTOTM Normalized: concertotm |
Device | Medtronic, Inc. | $4,954.58 | 5 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $2,664.21 | 8 | 2025 |
Source payment records
|
|||||
| GLIDESHEATH SLENDER Normalized: glidesheath slender |
Device | Terumo Medical Corporation | $1,199.70 | 7 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $666.35 | 17 | 2025 |
Source payment records
|
|||||
| ZOOM REPERFUSION CATHETER Normalized: zoom reperfusion catheter |
Device | Imperative Care, Inc | $500.20 | 8 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $458.06 | 4 | 2025 |
Source payment records
|
|||||
| SPIDERFX Normalized: spiderfx |
Device | Medtronic, Inc. | $246.29 | 2 | 2025 |
Source payment records
|
|||||
| ZOOM 88-T LARGE DISTAL PLATFORM Normalized: zoom 88 t large distal platform |
Device | Imperative Care, Inc | $205.25 | 4 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $139.51 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $139.34 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $125.40 | 2 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $125.40 | 2 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $125.40 | 2 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $125.40 | 2 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $125.40 | 2 | 2025 |
Source payment records
|
|||||
| TR BAND Normalized: tr band |
Device | Terumo Medical Corporation | $110.25 | 1 | 2025 |
Source payment records
|
|||||
| BioMimics 3D Vascular Stent System Normalized: biomimics 3d vascular stent system |
Device | Veryan Medical Incorporated | $47.74 | 2 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $45.58 | 2 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $44.04 | 2 | 2025 |
Source payment records
|
|||||
| SIR-Spheres Microspheres Normalized: sir spheres microspheres |
Device | Sirtex Medical Inc | $44.03 | 2 | 2025 |
Source payment records
|
|||||
| ANGIO-SEAL Normalized: angio seal |
Device | Terumo Medical Corporation | $40.65 | 3 | 2025 |
Source payment records
|
|||||
| MicroThermX Microwave Ablation System Normalized: microthermx microwave ablation system |
Device | Siemens Medical Solutions USA, Inc. | $38.85 | 1 | 2025 |
Source payment records
|
|||||
| SPINEJACK Normalized: spinejack |
Device | Stryker Corporation | $37.13 | 1 | 2025 |
Source payment records
|
|||||
| ERIC RETRIEVAL DEVICE Normalized: eric retrieval device |
Device | MicroVention, Inc. | $30.78 | 1 | 2025 |
Source payment records
|
|||||
| SCEPTER C Normalized: scepter c |
Device | MicroVention, Inc. | $30.78 | 1 | 2025 |
Source payment records
|
|||||
| STENT Normalized: stent |
Device | MicroVention, Inc. | $30.78 | 1 | 2025 |
Source payment records
|
|||||
| Certus 140 Normalized: certus 140 |
Device | Ethicon US, LLC | $27.10 | 1 | 2025 |
Source payment records
|
|||||
| TRINAV INFUSION SYSTEM Normalized: trinav infusion system |
Device | TriSalus Life Sciences, Inc. | $26.25 | 1 | 2025 |
Source payment records
|
|||||
| XACT Normalized: xact |
Device | Abbott Laboratories | $24.20 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $21.54 | 1 | 2025 |
Source payment records
|
|||||
| General - IO Ablation Normalized: general io ablation |
Device | Boston Scientific Corporation | $16.28 | 1 | 2025 |
Source payment records
|
|||||
| NAVICROSS Normalized: navicross |
Device | Terumo Medical Corporation | $12.12 | 2 | 2025 |
Source payment records
|
|||||
| HYDROPEARL Normalized: hydropearl |
Device | Terumo Medical Corporation | $9.47 | 2 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $8.71 | 1 | 2025 |
Source payment records
|
|||||
| COREVALVE EVOLUT R Normalized: corevalve evolut r |
Device | Medtronic, Inc. | $8.58 | 2 | 2025 |
Source payment records
|
|||||
| AUGMENT INJECTABLE Normalized: augment injectable |
Device | Stryker Corporation | $8.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 24 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14,271.04 · 86 records | Medtronic, Inc. | ANGIO-SEAL, ARTIX MT, AUGMENT INJECTABLE, AURYON LASER SYSTEM 100-120 VAC, AZUR CX DETACHABLE, BioMimics 3D Vascular Stent System, CONCERTOTM, COREVALVE EVOLUT R, Certus 140, ERIC RETRIEVAL DEVICE, ESPRIT, GLIDESHEATH SLENDER, GORE VIABAHN VBX Balloon Expandable Endo, General - IO Ablation, HYDROPEARL, MicroThermX Microwave Ablation System, NAVICROSS, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Ranger, RotarexS 6 F x 135 cm, SCEPTER C, SIR-Spheres Microspheres, SPIDERFX, SPINEJACK, STENT, SYMPHONY CATHETER, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, TR BAND, TRINAV INFUSION SYSTEM, XACT, ZOOM 88-T LARGE DISTAL PLATFORM, ZOOM REPERFUSION CATHETER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error